Clavulin



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 32.9%
Urinary Tract Infection 9.8%
Sinusitis 7.3%
Pneumonia 6.1%
Suicide Attempt 6.1%
Infectious Mononucleosis 3.7%
Pharyngitis 3.7%
Tonsillitis 3.7%
Acute Tonsillitis 2.4%
Bronchitis 2.4%
Depression 2.4%
Hypertension 2.4%
Insomnia 2.4%
Lymphangitis 2.4%
Menopause 2.4%
Nasopharyngitis 2.4%
Self-medication 2.4%
Viral Infection 2.4%
Bacterial Infection 1.2%
Blood Pressure 1.2%
Urticaria 27.8%
Vomiting 14.8%
Purpura 5.6%
Pyrexia 5.6%
Synovitis 5.6%
Convulsion 3.7%
Diarrhoea Haemorrhagic 3.7%
Febrile Convulsion 3.7%
Oedema 3.7%
Phlebitis 3.7%
Pneumonia 3.7%
Rash Maculo-papular 3.7%
Anaphylactic Shock 1.9%
Cardiac Arrest 1.9%
Delirium 1.9%
Diarrhoea 1.9%
Drug Administration Error 1.9%
Haemorrhage 1.9%
Hypertension 1.9%
Intentional Overdose 1.9%
Secondary
Drug Use For Unknown Indication 45.8%
Product Used For Unknown Indication 12.5%
Pulmonary Tuberculosis 5.2%
Oropharyngeal Pain 4.2%
Gastritis 3.1%
Hypertension 3.1%
Juvenile Idiopathic Arthritis 3.1%
Apical Granuloma 2.1%
Bronchopneumopathy 2.1%
Convulsion 2.1%
Intubation 2.1%
Postoperative Analgesia 2.1%
Postoperative Care 2.1%
Sedation 2.1%
Supplementation Therapy 2.1%
Vitamin Supplementation 2.1%
Antibiotic Prophylaxis 1.0%
Antiinflammatory Therapy 1.0%
Aspiration 1.0%
Glaucoma 1.0%
Toxic Skin Eruption 13.3%
Vomiting 13.3%
Diarrhoea 6.7%
Laryngeal Oedema 6.7%
Leukocytosis 6.7%
Leukopenia 6.7%
Otitis Externa 6.7%
Prothrombin Time Ratio Decreased 6.7%
Pruritus 6.7%
Sinusitis 6.7%
Urticaria 6.7%
Vision Blurred 6.7%
Wound Evisceration 6.7%
Concomitant
Drug Use For Unknown Indication 31.5%
Product Used For Unknown Indication 12.4%
Osteitis 9.5%
Diffuse Large B-cell Lymphoma 6.9%
Diabetes Mellitus 5.3%
Pain 4.5%
Rheumatoid Arthritis 4.5%
Hiv Infection 3.8%
Pyrexia 3.3%
Pain In Extremity 2.4%
Hypercholesterolaemia 2.1%
Constipation 1.9%
Hypertension 1.9%
Non-hodgkin's Lymphoma 1.7%
Pharyngolaryngeal Pain 1.7%
Bronchitis 1.4%
Urinary Tract Infection 1.4%
Antibiotic Prophylaxis 1.2%
Pneumonia 1.2%
Prophylaxis 1.2%
Osteitis 18.9%
White Blood Cell Count Decreased 11.3%
Urinary Tract Infection 7.5%
Vomiting 7.5%
Renal Failure Acute 5.7%
Shock 5.7%
Stevens-johnson Syndrome 5.7%
Neuroleptic Malignant Syndrome 3.8%
Oedema Peripheral 3.8%
Pruritus 3.8%
Pulmonary Oedema 3.8%
Renal Impairment 3.8%
Retinal Haemorrhage 3.8%
Wheezing 3.8%
Budd-chiari Syndrome 1.9%
Drug Interaction 1.9%
Escherichia Infection 1.9%
Extravasation 1.9%
Fistula 1.9%
Haematoma 1.9%
Interacting
Product Used For Unknown Indication 50.0%
Atrial Fibrillation 25.0%
Bronchopneumonia 25.0%
Haematoma 50.0%
Hypersensitivity 50.0%